Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 211

Similar articles for PubMed (Select 18096682)

1.

Detection of Huntington's disease decades before diagnosis: the Predict-HD study.

Paulsen JS, Langbehn DR, Stout JC, Aylward E, Ross CA, Nance M, Guttman M, Johnson S, MacDonald M, Beglinger LJ, Duff K, Kayson E, Biglan K, Shoulson I, Oakes D, Hayden M; Predict-HD Investigators and Coordinators of the Huntington Study Group.

J Neurol Neurosurg Psychiatry. 2008 Aug;79(8):874-80. Epub 2007 Dec 20.

2.

Preparing for preventive clinical trials: the Predict-HD study.

Paulsen JS, Hayden M, Stout JC, Langbehn DR, Aylward E, Ross CA, Guttman M, Nance M, Kieburtz K, Oakes D, Shoulson I, Kayson E, Johnson S, Penziner E; Predict-HD Investigators of the Huntington Study Group.

Arch Neurol. 2006 Jun;63(6):883-90.

PMID:
16769871
3.

Are cognitive changes progressive in prediagnostic HD?

Stout JC, Weaver M, Solomon AC, Queller S, Hui S, Johnson SA, Gray J, Beristain X, Wojcieszek J, Foroud T.

Cogn Behav Neurol. 2007 Dec;20(4):212-8.

PMID:
18091069
4.

The neurology and natural history of patients with indeterminate CAG repeat length mutations of the Huntington disease gene.

Panegyres PK, Goh JG.

J Neurol Sci. 2011 Feb 15;301(1-2):14-20. doi: 10.1016/j.jns.2010.11.015. Epub 2010 Dec 13.

PMID:
21147489
5.

Altered frontostriatal coupling in pre-manifest Huntington's disease: effects of increasing cognitive load.

Wolf RC, Sambataro F, Vasic N, Schönfeldt-Lecuona C, Ecker D, Landwehrmeyer B.

Eur J Neurol. 2008 Nov;15(11):1180-90. doi: 10.1111/j.1468-1331.2008.02253.x. Epub 2008 Aug 27.

PMID:
18754766
6.

Reduced basal ganglia blood flow and volume in pre-symptomatic, gene-tested persons at-risk for Huntington's disease.

Harris GJ, Codori AM, Lewis RF, Schmidt E, Bedi A, Brandt J.

Brain. 1999 Sep;122 ( Pt 9):1667-78.

7.

Neuropsychological manifestations of the genetic mutation for Huntington's disease in presymptomatic individuals.

Brandt J, Shpritz B, Codori AM, Margolis R, Rosenblatt A.

J Int Neuropsychol Soc. 2002 Nov;8(7):918-24.

PMID:
12405543
8.

Psychomotor, executive, and memory function in preclinical Huntington's disease.

Snowden JS, Craufurd D, Thompson J, Neary D.

J Clin Exp Neuropsychol. 2002 Apr;24(2):133-45.

PMID:
11992196
9.

Neurocognitive signs in prodromal Huntington disease.

Stout JC, Paulsen JS, Queller S, Solomon AC, Whitlock KB, Campbell JC, Carlozzi N, Duff K, Beglinger LJ, Langbehn DR, Johnson SA, Biglan KM, Aylward EH.

Neuropsychology. 2011 Jan;25(1):1-14. doi: 10.1037/a0020937.

10.

Cognitive changes in patients with Huntington's disease (HD) and asymptomatic carriers of the HD mutation--a longitudinal follow-up study.

Lemiere J, Decruyenaere M, Evers-Kiebooms G, Vandenbussche E, Dom R.

J Neurol. 2004 Aug;251(8):935-42.

PMID:
15316797
11.

Aberrant connectivity of lateral prefrontal networks in presymptomatic Huntington's disease.

Wolf RC, Sambataro F, Vasic N, Schönfeldt-Lecuona C, Ecker D, Landwehrmeyer B.

Exp Neurol. 2008 Sep;213(1):137-44. doi: 10.1016/j.expneurol.2008.05.017. Epub 2008 Jul 11.

PMID:
18588876
12.

[From gene to disease; HD gene and Huntington disease].

Maat-Kievit JA, Losekoot M, Roos RA.

Ned Tijdschr Geneeskd. 2001 Nov 3;145(44):2120-3. Review. Dutch.

PMID:
11723754
13.

Cognitive changes in asymptomatic carriers of the Huntington disease mutation gene.

Verny C, Allain P, Prudean A, Malinge MC, Gohier B, Scherer C, Bonneau D, Dubas F, Le Gall D.

Eur J Neurol. 2007 Dec;14(12):1344-50. Epub 2007 Oct 17.

PMID:
17941857
14.

Onset and rate of striatal atrophy in preclinical Huntington disease.

Aylward EH, Sparks BF, Field KM, Yallapragada V, Shpritz BD, Rosenblatt A, Brandt J, Gourley LM, Liang K, Zhou H, Margolis RL, Ross CA.

Neurology. 2004 Jul 13;63(1):66-72.

PMID:
15249612
15.

Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.

Tabrizi SJ, Scahill RI, Owen G, Durr A, Leavitt BR, Roos RA, Borowsky B, Landwehrmeyer B, Frost C, Johnson H, Craufurd D, Reilmann R, Stout JC, Langbehn DR; TRACK-HD Investigators.

Lancet Neurol. 2013 Jul;12(7):637-49. doi: 10.1016/S1474-4422(13)70088-7. Epub 2013 May 9.

PMID:
23664844
16.

[Huntington chorea. Molecular genetic principles, mutation detection and predictive diagnosis].

Zühlke C, Thies U.

Nervenarzt. 1996 Jan;67(1):25-35. German.

PMID:
8676985
17.

Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study.

Paulsen JS, Long JD, Ross CA, Harrington DL, Erwin CJ, Williams JK, Westervelt HJ, Johnson HJ, Aylward EH, Zhang Y, Bockholt HJ, Barker RA; PREDICT-HD Investigators and Coordinators of the Huntington Study Group.

Lancet Neurol. 2014 Dec;13(12):1193-201. doi: 10.1016/S1474-4422(14)70238-8. Epub 2014 Nov 3.

PMID:
25453459
18.

Progression of structural neuropathology in preclinical Huntington's disease: a tensor based morphometry study.

Kipps CM, Duggins AJ, Mahant N, Gomes L, Ashburner J, McCusker EA.

J Neurol Neurosurg Psychiatry. 2005 May;76(5):650-5.

19.

Longitudinal analysis of regional grey matter loss in Huntington disease: effects of the length of the expanded CAG repeat.

Ruocco HH, Bonilha L, Li LM, Lopes-Cendes I, Cendes F.

J Neurol Neurosurg Psychiatry. 2008 Feb;79(2):130-5. Epub 2007 Jul 5.

PMID:
17615168
20.

Modeling longitudinal change in motor and cognitive processing speed in presymptomatic Huntington's disease.

Maroof DA, Gross AL, Brandt J.

J Clin Exp Neuropsychol. 2011 Oct;33(8):901-9. doi: 10.1080/13803395.2011.574606. Epub 2011 Jun 2.

PMID:
21644140
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk